Airwallex, a leading global financial platform for modern businesses, has raised US$330 million in a Series G funding round, led by Addition and with participation from T. Rowe Price, Activant,
Hot Posts174- Page
Community injury cases affect more than just individuals. They ripple through families, workplaces, and neighborhoods, often leaving lasting physical, emotional, and financial consequences. When someone is injured due to negligence
On Friday, December 12, 2025, Sidley successfully obtained confirmation of Prospect Medical Holdings, Inc.’s (Prospect) Chapter 11 plan in the U.S. Bankruptcy Court for the Northern District of Texas. Overruling
Leading global law firm Herbert Smith Freehills Kramer has advised OX2 on its investment in three onshore wind farms – Kannisto, located in Central Ostrobothnia and Korkeamaa and Salo-Ylikoski, located
Sidley represented Wealthfront as regulatory counsel in its initial public offering (IPO) and listing on the New York Stock Exchange. The offering included 34,615 shares of its common stock at
Great Mountain Partners (GMP) announced the closing of Saranac Holdings LP, a US$600M single-investor fund formed to pursue investments across the media and entertainment ecosystem, including music, film and television,
December 12, 2025 Sidley represented Immunovant, Inc., a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, in its US$550 million underwritten offering of 26,200,000 shares
Press releases|22 December 2025 Silicon Valley, 22 December 2025 – Global law firm Hogan Lovells has advised Sony Music Entertainment (Japan) Inc. “SMEJ” and Sony Pictures Entertainment Inc. “SPE” in
Sidley is representing Fortidia (the “Company”) in its definitive agreement for BC Partners, a leading international investment firm, to acquire a majority stake in the Company from the founding Fiorelli
Vera Therapeutics, Inc., a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, announced an underwritten public offering of 7,058,824 shares of
